nodes	percent_of_prediction	percent_of_DWPC	metapath
Gefitinib—ORM1—saliva—attention deficit hyperactivity disorder	0.0435	0.0621	CbGeAlD
Gefitinib—SBK1—midbrain—attention deficit hyperactivity disorder	0.0229	0.0327	CbGeAlD
Gefitinib—CSNK1E—forebrain—attention deficit hyperactivity disorder	0.0192	0.0274	CbGeAlD
Gefitinib—ERBB3—forebrain—attention deficit hyperactivity disorder	0.0185	0.0264	CbGeAlD
Gefitinib—SBK1—cerebellum—attention deficit hyperactivity disorder	0.0177	0.0253	CbGeAlD
Gefitinib—MKNK2—cardiovascular system—attention deficit hyperactivity disorder	0.0149	0.0212	CbGeAlD
Gefitinib—EPHA6—nervous system—attention deficit hyperactivity disorder	0.0147	0.021	CbGeAlD
Gefitinib—MKNK1—cardiovascular system—attention deficit hyperactivity disorder	0.0147	0.021	CbGeAlD
Gefitinib—SBK1—brain—attention deficit hyperactivity disorder	0.0144	0.0206	CbGeAlD
Gefitinib—HIPK4—brain—attention deficit hyperactivity disorder	0.0142	0.0203	CbGeAlD
Gefitinib—EPHA6—central nervous system—attention deficit hyperactivity disorder	0.0142	0.0202	CbGeAlD
Gefitinib—MAP3K19—nervous system—attention deficit hyperactivity disorder	0.0134	0.0191	CbGeAlD
Gefitinib—MAP3K19—central nervous system—attention deficit hyperactivity disorder	0.0129	0.0184	CbGeAlD
Gefitinib—CSNK1E—midbrain—attention deficit hyperactivity disorder	0.0127	0.0181	CbGeAlD
Gefitinib—CHEK2—brain—attention deficit hyperactivity disorder	0.0125	0.0179	CbGeAlD
Gefitinib—ERBB3—midbrain—attention deficit hyperactivity disorder	0.0122	0.0174	CbGeAlD
Gefitinib—STK10—cardiovascular system—attention deficit hyperactivity disorder	0.0121	0.0173	CbGeAlD
Gefitinib—MKNK2—midbrain—attention deficit hyperactivity disorder	0.0116	0.0166	CbGeAlD
Gefitinib—IRAK1—midbrain—attention deficit hyperactivity disorder	0.0116	0.0166	CbGeAlD
Gefitinib—MKNK1—midbrain—attention deficit hyperactivity disorder	0.0115	0.0164	CbGeAlD
Gefitinib—EPHA6—brain—attention deficit hyperactivity disorder	0.0112	0.0161	CbGeAlD
Gefitinib—Iloperidone—ADRA2C—attention deficit hyperactivity disorder	0.0112	0.15	CrCbGaD
Gefitinib—MAP2K5—cardiovascular system—attention deficit hyperactivity disorder	0.0108	0.0154	CbGeAlD
Gefitinib—CSNK1E—nervous system—attention deficit hyperactivity disorder	0.0104	0.0149	CbGeAlD
Gefitinib—IRAK4—nervous system—attention deficit hyperactivity disorder	0.0102	0.0146	CbGeAlD
Gefitinib—MAP3K19—brain—attention deficit hyperactivity disorder	0.0102	0.0146	CbGeAlD
Gefitinib—EGFR—cerebellum—attention deficit hyperactivity disorder	0.0102	0.0145	CbGeAlD
Gefitinib—ERBB3—nervous system—attention deficit hyperactivity disorder	0.01	0.0143	CbGeAlD
Gefitinib—CSNK1E—central nervous system—attention deficit hyperactivity disorder	0.01	0.0143	CbGeAlD
Gefitinib—IRAK4—central nervous system—attention deficit hyperactivity disorder	0.00986	0.0141	CbGeAlD
Gefitinib—CSNK1E—cerebellum—attention deficit hyperactivity disorder	0.00979	0.014	CbGeAlD
Gefitinib—ERBB3—central nervous system—attention deficit hyperactivity disorder	0.00966	0.0138	CbGeAlD
Gefitinib—IRAK4—cerebellum—attention deficit hyperactivity disorder	0.00964	0.0138	CbGeAlD
Gefitinib—MKNK2—nervous system—attention deficit hyperactivity disorder	0.00954	0.0136	CbGeAlD
Gefitinib—ERBB3—cerebellum—attention deficit hyperactivity disorder	0.00945	0.0135	CbGeAlD
Gefitinib—MKNK1—nervous system—attention deficit hyperactivity disorder	0.00942	0.0135	CbGeAlD
Gefitinib—MKNK2—central nervous system—attention deficit hyperactivity disorder	0.00919	0.0131	CbGeAlD
Gefitinib—MKNK1—central nervous system—attention deficit hyperactivity disorder	0.00907	0.013	CbGeAlD
Gefitinib—IRAK1—cerebellum—attention deficit hyperactivity disorder	0.00898	0.0128	CbGeAlD
Gefitinib—MKNK2—cerebellum—attention deficit hyperactivity disorder	0.00898	0.0128	CbGeAlD
Gefitinib—MKNK1—cerebellum—attention deficit hyperactivity disorder	0.00887	0.0127	CbGeAlD
Gefitinib—MAP2K5—midbrain—attention deficit hyperactivity disorder	0.00843	0.012	CbGeAlD
Gefitinib—EGFR—brain—attention deficit hyperactivity disorder	0.00827	0.0118	CbGeAlD
Gefitinib—CSNK1E—brain—attention deficit hyperactivity disorder	0.00795	0.0114	CbGeAlD
Gefitinib—IRAK4—brain—attention deficit hyperactivity disorder	0.00783	0.0112	CbGeAlD
Gefitinib—STK10—nervous system—attention deficit hyperactivity disorder	0.00776	0.0111	CbGeAlD
Gefitinib—Minaprine—MAOA—attention deficit hyperactivity disorder	0.00774	0.104	CrCbGaD
Gefitinib—ERBB3—brain—attention deficit hyperactivity disorder	0.00767	0.011	CbGeAlD
Gefitinib—STK10—central nervous system—attention deficit hyperactivity disorder	0.00747	0.0107	CbGeAlD
Gefitinib—STK10—cerebellum—attention deficit hyperactivity disorder	0.0073	0.0104	CbGeAlD
Gefitinib—MKNK2—brain—attention deficit hyperactivity disorder	0.0073	0.0104	CbGeAlD
Gefitinib—IRAK1—brain—attention deficit hyperactivity disorder	0.0073	0.0104	CbGeAlD
Gefitinib—MKNK1—brain—attention deficit hyperactivity disorder	0.0072	0.0103	CbGeAlD
Gefitinib—Minaprine—DRD1—attention deficit hyperactivity disorder	0.00704	0.0947	CrCbGaD
Gefitinib—MAP2K5—nervous system—attention deficit hyperactivity disorder	0.00693	0.0099	CbGeAlD
Gefitinib—MAP2K5—central nervous system—attention deficit hyperactivity disorder	0.00667	0.00953	CbGeAlD
Gefitinib—MAP2K5—cerebellum—attention deficit hyperactivity disorder	0.00652	0.00932	CbGeAlD
Gefitinib—Iloperidone—DRD4—attention deficit hyperactivity disorder	0.00607	0.0816	CrCbGaD
Gefitinib—STK10—brain—attention deficit hyperactivity disorder	0.00593	0.00847	CbGeAlD
Gefitinib—ORM1—nervous system—attention deficit hyperactivity disorder	0.00563	0.00804	CbGeAlD
Gefitinib—ORM1—central nervous system—attention deficit hyperactivity disorder	0.00542	0.00774	CbGeAlD
Gefitinib—MAP2K5—brain—attention deficit hyperactivity disorder	0.0053	0.00757	CbGeAlD
Gefitinib—Iloperidone—DRD3—attention deficit hyperactivity disorder	0.00523	0.0704	CrCbGaD
Gefitinib—Iloperidone—DRD1—attention deficit hyperactivity disorder	0.00514	0.0691	CrCbGaD
Gefitinib—Minaprine—SLC6A4—attention deficit hyperactivity disorder	0.00499	0.0671	CrCbGaD
Gefitinib—Minaprine—DRD2—attention deficit hyperactivity disorder	0.00496	0.0668	CrCbGaD
Gefitinib—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.0048	0.00685	CbGeAlD
Gefitinib—Iloperidone—ADRA2A—attention deficit hyperactivity disorder	0.00477	0.0642	CrCbGaD
Gefitinib—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.00426	0.00608	CbGeAlD
Gefitinib—ABCG2—midbrain—attention deficit hyperactivity disorder	0.0041	0.00586	CbGeAlD
Gefitinib—Cisapride—DRD2—attention deficit hyperactivity disorder	0.00392	0.0528	CrCbGaD
Gefitinib—Minaprine—HTR2A—attention deficit hyperactivity disorder	0.00384	0.0516	CrCbGaD
Gefitinib—ALB—brain—attention deficit hyperactivity disorder	0.00377	0.00539	CbGeAlD
Gefitinib—Iloperidone—DRD2—attention deficit hyperactivity disorder	0.00362	0.0487	CrCbGaD
Gefitinib—CYP1A1—nervous system—attention deficit hyperactivity disorder	0.0032	0.00457	CbGeAlD
Gefitinib—ABCG2—cerebellum—attention deficit hyperactivity disorder	0.00317	0.00453	CbGeAlD
Gefitinib—CYP1A1—central nervous system—attention deficit hyperactivity disorder	0.00308	0.0044	CbGeAlD
Gefitinib—ABCB1—forebrain—attention deficit hyperactivity disorder	0.00306	0.00438	CbGeAlD
Gefitinib—Cisapride—HTR2A—attention deficit hyperactivity disorder	0.00303	0.0408	CrCbGaD
Gefitinib—Iloperidone—HTR2A—attention deficit hyperactivity disorder	0.0028	0.0376	CrCbGaD
Gefitinib—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.00259	0.0037	CbGeAlD
Gefitinib—ABCG2—brain—attention deficit hyperactivity disorder	0.00258	0.00368	CbGeAlD
Gefitinib—CYP1A1—brain—attention deficit hyperactivity disorder	0.00245	0.0035	CbGeAlD
Gefitinib—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00235	0.00336	CbGeAlD
Gefitinib—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.00231	0.0033	CbGeAlD
Gefitinib—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00226	0.00323	CbGeAlD
Gefitinib—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.00223	0.00318	CbGeAlD
Gefitinib—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.00217	0.00311	CbGeAlD
Gefitinib—ABCB1—midbrain—attention deficit hyperactivity disorder	0.00202	0.00289	CbGeAlD
Gefitinib—CYP2D6—brain—attention deficit hyperactivity disorder	0.00177	0.00252	CbGeAlD
Gefitinib—ABCB1—nervous system—attention deficit hyperactivity disorder	0.00166	0.00238	CbGeAlD
Gefitinib—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.0016	0.00229	CbGeAlD
Gefitinib—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.00156	0.00224	CbGeAlD
Gefitinib—ABCB1—brain—attention deficit hyperactivity disorder	0.00127	0.00182	CbGeAlD
Gefitinib—CYP1A1—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.000486	0.00215	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways in Glioblastoma—EP300—attention deficit hyperactivity disorder	0.000485	0.00215	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000484	0.00214	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000476	0.00211	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling by WNT in cancer—EP300—attention deficit hyperactivity disorder	0.00047	0.00208	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000463	0.00205	CbGpPWpGaD
Gefitinib—EGFR—Androgen receptor signaling pathway—EP300—attention deficit hyperactivity disorder	0.000454	0.00201	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000447	0.00198	CbGpPWpGaD
Gefitinib—ALB—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000444	0.00197	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.000443	0.00196	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00044	0.00195	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—POLR3A—attention deficit hyperactivity disorder	0.000436	0.00193	CbGpPWpGaD
Gefitinib—ALB—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000424	0.00188	CbGpPWpGaD
Gefitinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.000423	0.00187	CbGpPWpGaD
Gefitinib—CYP3A5—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000418	0.00185	CbGpPWpGaD
Gefitinib—CYP3A5—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000415	0.00184	CbGpPWpGaD
Gefitinib—CYP3A5—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000412	0.00183	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.000405	0.0018	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000398	0.00176	CbGpPWpGaD
Gefitinib—EGFR—Immune System—MB21D1—attention deficit hyperactivity disorder	0.000397	0.00176	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—SNAP25—attention deficit hyperactivity disorder	0.000397	0.00176	CbGpPWpGaD
Gefitinib—CYP1A1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000395	0.00175	CbGpPWpGaD
Gefitinib—CYP1A1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000392	0.00174	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00039	0.00173	CbGpPWpGaD
Gefitinib—CYP1A1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000389	0.00173	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000389	0.00172	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling by Wnt—EP300—attention deficit hyperactivity disorder	0.000387	0.00172	CbGpPWpGaD
Gefitinib—EGFR—Immune System—STUB1—attention deficit hyperactivity disorder	0.000385	0.0017	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000384	0.0017	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000384	0.0017	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000382	0.00169	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000376	0.00167	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000372	0.00165	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000371	0.00164	CbGpPWpGaD
Gefitinib—ALB—Platelet activation, signaling and aggregation—ADRA2A—attention deficit hyperactivity disorder	0.00037	0.00164	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000369	0.00163	CbGpPWpGaD
Gefitinib—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000363	0.00161	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.000363	0.00161	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000362	0.0016	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000357	0.00158	CbGpPWpGaD
Gefitinib—EGFR—Disease—STUB1—attention deficit hyperactivity disorder	0.000355	0.00157	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000354	0.00157	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000346	0.00153	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000342	0.00152	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.00034	0.00151	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000336	0.00149	CbGpPWpGaD
Gefitinib—CYP2C19—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000323	0.00143	CbGpPWpGaD
Gefitinib—EPHA6—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000322	0.00143	CbGpPWpGaD
Gefitinib—CYP2C19—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000321	0.00142	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000319	0.00142	CbGpPWpGaD
Gefitinib—CYP2C19—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000319	0.00141	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000318	0.00141	CbGpPWpGaD
Gefitinib—EGFR—Direct p53 effectors—EP300—attention deficit hyperactivity disorder	0.000316	0.0014	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000313	0.00139	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000313	0.00139	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000307	0.00136	CbGpPWpGaD
Gefitinib—ALB—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000304	0.00135	CbGpPWpGaD
Gefitinib—ERBB3—Disease—SNAP25—attention deficit hyperactivity disorder	0.000302	0.00134	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000299	0.00132	CbGpPWpGaD
Gefitinib—EGFR—Integrated Breast Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000297	0.00132	CbGpPWpGaD
Gefitinib—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000297	0.00132	CbGpPWpGaD
Gefitinib—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000295	0.00131	CbGpPWpGaD
Gefitinib—CYP2C9—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000295	0.00131	CbGpPWpGaD
Gefitinib—CHEK2—Cell Cycle—EP300—attention deficit hyperactivity disorder	0.000293	0.0013	CbGpPWpGaD
Gefitinib—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000293	0.0013	CbGpPWpGaD
Gefitinib—CYP2C9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000292	0.0013	CbGpPWpGaD
Gefitinib—EGFR—Immune System—POLR3A—attention deficit hyperactivity disorder	0.000291	0.00129	CbGpPWpGaD
Gefitinib—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.000291	0.00129	CbGpPWpGaD
Gefitinib—CYP2C9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000291	0.00129	CbGpPWpGaD
Gefitinib—CSNK1E—Cell Cycle, Mitotic—EP300—attention deficit hyperactivity disorder	0.000281	0.00125	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000278	0.00123	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.000278	0.00123	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00027	0.0012	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000269	0.00119	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000265	0.00117	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000261	0.00116	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000261	0.00115	CbGpPWpGaD
Gefitinib—CSNK1E—Cell Cycle—EP300—attention deficit hyperactivity disorder	0.000251	0.00111	CbGpPWpGaD
Gefitinib—ABCG2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00025	0.00111	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000249	0.0011	CbGpPWpGaD
Gefitinib—EGFR—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000246	0.00109	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000246	0.00109	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000243	0.00108	CbGpPWpGaD
Gefitinib—CYP1A1—PPARA activates gene expression—EP300—attention deficit hyperactivity disorder	0.000242	0.00107	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000238	0.00106	CbGpPWpGaD
Gefitinib—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—attention deficit hyperactivity disorder	0.000237	0.00105	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000236	0.00105	CbGpPWpGaD
Gefitinib—IRAK4—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000229	0.00102	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000228	0.00101	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00022	0.000973	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000219	0.000971	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000217	0.000961	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000215	0.000951	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000214	0.000946	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000213	0.000943	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000212	0.000938	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000209	0.000927	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000209	0.000927	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000207	0.000915	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000205	0.000909	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000205	0.000909	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000202	0.000893	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.0002	0.000884	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000199	0.000882	CbGpPWpGaD
Gefitinib—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000194	0.000861	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000193	0.000856	CbGpPWpGaD
Gefitinib—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000193	0.000855	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000192	0.000852	CbGpPWpGaD
Gefitinib—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000192	0.000849	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.000191	0.000845	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00019	0.000842	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00019	0.00084	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000188	0.000831	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000185	0.000822	CbGpPWpGaD
Gefitinib—ERBB3—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000183	0.00081	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000176	0.000781	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000175	0.000774	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000171	0.000757	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000171	0.000756	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.00017	0.000755	CbGpPWpGaD
Gefitinib—EGFR—Disease—SNAP25—attention deficit hyperactivity disorder	0.000168	0.000746	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000168	0.000744	CbGpPWpGaD
Gefitinib—MKNK1—Disease—EP300—attention deficit hyperactivity disorder	0.000166	0.000735	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000166	0.000734	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000165	0.000729	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000165	0.000729	CbGpPWpGaD
Gefitinib—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—attention deficit hyperactivity disorder	0.000163	0.000723	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000162	0.000718	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000161	0.000715	CbGpPWpGaD
Gefitinib—ALB—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000155	0.000685	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000154	0.000684	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000152	0.000674	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000151	0.000667	CbGpPWpGaD
Gefitinib—ALB—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000147	0.000652	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000145	0.000643	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000135	0.0006	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000135	0.000597	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—EP300—attention deficit hyperactivity disorder	0.000133	0.000591	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000132	0.000585	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000132	0.000583	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.00013	0.000575	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—EP300—attention deficit hyperactivity disorder	0.000129	0.000571	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000129	0.000571	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000127	0.000562	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000125	0.000555	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000124	0.000551	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000122	0.000542	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000122	0.000538	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00012	0.000534	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000118	0.000523	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000118	0.000523	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000118	0.000522	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000116	0.000515	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000116	0.000514	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000115	0.00051	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000114	0.000506	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000112	0.000497	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000111	0.000494	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000111	0.000494	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000111	0.000491	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00011	0.000486	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000108	0.000479	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000108	0.000478	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—EP300—attention deficit hyperactivity disorder	0.000106	0.000472	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000103	0.000457	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000102	0.000452	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000102	0.000451	CbGpPWpGaD
Gefitinib—ALB—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000102	0.00045	CbGpPWpGaD
Gefitinib—ALB—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000102	0.00045	CbGpPWpGaD
Gefitinib—ALB—Metabolism—DPYD—attention deficit hyperactivity disorder	9.99e-05	0.000443	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—COMT—attention deficit hyperactivity disorder	9.97e-05	0.000442	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—MAOA—attention deficit hyperactivity disorder	9.9e-05	0.000439	CbGpPWpGaD
Gefitinib—ERBB3—Disease—EP300—attention deficit hyperactivity disorder	9.83e-05	0.000435	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—SNAP25—attention deficit hyperactivity disorder	9.43e-05	0.000418	CbGpPWpGaD
Gefitinib—ALB—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.29e-05	0.000412	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	9.12e-05	0.000404	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	9.12e-05	0.000404	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—EP300—attention deficit hyperactivity disorder	9.03e-05	0.0004	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.98e-05	0.000398	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	8.97e-05	0.000397	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.91e-05	0.000395	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	8.9e-05	0.000394	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	8.9e-05	0.000394	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—EP300—attention deficit hyperactivity disorder	8.86e-05	0.000393	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	8.76e-05	0.000388	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.48e-05	0.000376	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	8.39e-05	0.000372	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	8.39e-05	0.000372	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	8.34e-05	0.00037	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	8.31e-05	0.000368	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	8.31e-05	0.000368	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	8.25e-05	0.000366	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	8.18e-05	0.000362	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	8.14e-05	0.000361	CbGpPWpGaD
Gefitinib—ALB—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.12e-05	0.00036	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	7.94e-05	0.000352	CbGpPWpGaD
Gefitinib—ALB—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.73e-05	0.000343	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	7.67e-05	0.00034	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	7.6e-05	0.000337	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	7.29e-05	0.000323	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.23e-05	0.00032	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—COMT—attention deficit hyperactivity disorder	7.15e-05	0.000317	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.14e-05	0.000316	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	7.12e-05	0.000315	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—MAOA—attention deficit hyperactivity disorder	7.1e-05	0.000314	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6.94e-05	0.000307	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.88e-05	0.000305	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6.77e-05	0.0003	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—COMT—attention deficit hyperactivity disorder	6.75e-05	0.000299	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.7e-05	0.000297	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—MAOA—attention deficit hyperactivity disorder	6.7e-05	0.000297	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.65e-05	0.000295	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—EP300—attention deficit hyperactivity disorder	6.51e-05	0.000288	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	6.5e-05	0.000288	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6.38e-05	0.000283	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6.33e-05	0.00028	CbGpPWpGaD
Gefitinib—ALB—Metabolism—COMT—attention deficit hyperactivity disorder	6.15e-05	0.000273	CbGpPWpGaD
Gefitinib—ALB—Metabolism—MAOA—attention deficit hyperactivity disorder	6.11e-05	0.000271	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	5.93e-05	0.000263	CbGpPWpGaD
Gefitinib—EGFR—Immune System—EP300—attention deficit hyperactivity disorder	5.93e-05	0.000263	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.73e-05	0.000254	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	5.52e-05	0.000245	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	5.49e-05	0.000243	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	5.48e-05	0.000243	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	5.48e-05	0.000243	CbGpPWpGaD
Gefitinib—EGFR—Disease—EP300—attention deficit hyperactivity disorder	5.47e-05	0.000242	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	5.39e-05	0.000239	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	5.39e-05	0.000239	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	5.35e-05	0.000237	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	5.32e-05	0.000236	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	5.08e-05	0.000225	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	5.05e-05	0.000224	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	5.04e-05	0.000223	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	5.02e-05	0.000222	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	5e-05	0.000222	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	4.85e-05	0.000215	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	4.38e-05	0.000194	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—EP300—attention deficit hyperactivity disorder	4.28e-05	0.00019	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	4.17e-05	0.000185	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.83e-05	0.00017	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	3.32e-05	0.000147	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	3.3e-05	0.000146	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—EP300—attention deficit hyperactivity disorder	3.06e-05	0.000136	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—EP300—attention deficit hyperactivity disorder	2.9e-05	0.000128	CbGpPWpGaD
Gefitinib—ALB—Metabolism—EP300—attention deficit hyperactivity disorder	2.64e-05	0.000117	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	2.37e-05	0.000105	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	2.31e-05	0.000102	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	2.18e-05	9.65e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	2.16e-05	9.57e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	1.42e-05	6.31e-05	CbGpPWpGaD
